Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial

BACKGROUND: Blood pressure (BP) control and reduction of urinary protein excretion using agents that block the renin–angiotensin aldosterone system are the mainstay of therapy for chronic kidney disease (CKD). Research has confirmed the benefits in mild CKD, but data on angiotensin-converting enzyme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrol Dial Transplant
Hauptverfasser: Bhandari, Sunil, Ives, Natalie, Brettell, Elizabeth A., Valente, Marie, Cockwell, Paul, Topham, Peter S., Cleland, John G., Khwaja, Arif, El Nahas, Meguid
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2016
Schlagworte:
CLINICAL SCIENCE
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4725389/
https://ncbi.nlm.nih.gov/pubmed/26429974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv346
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge